JoshuaDavidPalmerMD

Radiation Oncology • Columbus, OH

Benign Diseases, Central Nervous System Cancer, Pediatric Radiation Oncology

Associate Professor

Join to view full profile

Dr. Palmer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Palmer's full profile

Already have an account?

Office
460 W 10th Ave
2nd Floor
Columbus, OH 43210
Fax+1 614-366-8707

Summary

Dr. Joshua Palmer is a radiation oncologist in Columbus, OH and is affiliated with multiple hospitals in the area, including James Cancer Hospital and Solove Research Institute, Ohio State University Wexner Medical Center, and Chillicothe Veterans Affairs Medical Center. He received his medical degree from University of Miami Miller School of Medicine and has been in practice 6 years. He also speaks multiple languages, including Spanish. He specializes in benign diseases and central nervous system cancer and is experienced in head and neck radiation oncology, central nervous system radiation oncology, and clinical and translational oncology.

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Radiation Oncology, 2012 - 2016
NYU Grossman School of MedicineInternship, Internal Medicine, 2011 - 2012
University of Miami Leonard M. Miller School of MedicineClass of 2011, MD, Alpha Omega Alpha
University of MinnesotaB.S., Biochemistry and Genetics, Cell, and Developmental biology, Summa Cum Laude, 2003 - 2007

Certifications & Licensure

OH State Medical License 2016 - 2026
DE State Medical License 2015 - 2017
PA State Medical License 2012 - 2016
MO State Medical License 2014 - 2015
American Board of Radiology Radiation Oncology
Gamma KnifePrinciples and practice of Gamma Knife image guided Radiosurgery
NovoTTFCertified prescriber for NovoTTF

Awards, Honors, & Recognition

Publication Excellence Award Radiation Oncology Institute, 2023
Honourable Mention 2023 Most Significant Alliance Manuscripts Alliance For Clinical Trials in Oncology, 2023
Minority Summer Fellowship Mentor ASTRO, 2022
Clinical Educator of the Year Ohio State University, Department of Radiation Oncology, 2021
ASCO Conquer Cancer Foundation Oncology Trainee Award American Society of Clinical Oncology, 2015
ACRO Essay Award American College of Radiation Oncology, 2015
ASCO/AACR Workshop on Methods in Clinical Cancer Research ASCO/AACR VAIL, CO, 2015
2015 SNO Best Oral Presentation Award Society for NeuroOncology, 2015
Jefferson Faculty Association Resident Award for Clinical Excellence, Patient Service, Empathy and Professionalism, Finalist Thomas Jefferson University, 2014
Thomas Jefferson University All-Star Award for Excellence in Clinical Care Thomas Jefferson University, 2014
Post-graduate Clinical Research Award Alpha Omega Alpha Honor Society, 2014
Academic Excellence Award University of Miami School of Medicine, 2008
College of Biological Sciences Gold Medallion in Basic Science Research University of Minnesota, 2007
Selected for the University Honors Program in the College of Biological Sciences University of Minnesota, 2004
Inductee Alpha Omega Alpha Honor Medical Society, 2011
Join now to see all

Clinical Trials

Neuropsychological Care for Maintaining Quality of Life After Radiation Therapy in Patients With Brain Metastases Start of enrollment: 2022 Aug 30
Recruiting
Not Applicable
Roles: Contact, Principal Investigator
Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer Start of enrollment: 2019 Jun 11
Terminated
Phase 2
Roles: Principal Investigator, Contact
Trametinib With or Without Whole Brain Radiation Therapy in Treating Patients With Brain Metastases Start of enrollment: 2014 Apr 28
Active, not recruiting
Phase 1
Keto-Brain:Investigating the Use of Ketogenic Diets in Brain Metastases Start of enrollment: 2022 Sep 26
Recruiting
Not Applicable
Single Fraction Stereotactic Radiosurgery Compared With Fractionated Stereotactic Radiosurgery in Treating Patients With Resected Metastatic Brain Disease Start of enrollment: 2019 Oct 11
Active, not recruiting
Phase 3
Testing the Addition of Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in People With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery Start of enrollment: 2020 Dec 15
Recruiting
Phase 3
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability Start of enrollment: 2021 Mar 24
Recruiting
Phase 3
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL) Start of enrollment: 2020 Dec 04
Suspended
Phase 2
A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma Start of enrollment: 2022 Sep 21
Recruiting
Not Applicable
Roles: Contact
Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements Start of enrollment: 2024 Mar 07
Recruiting
Phase 1, Phase 2
Roles: Sponsor-Investigator, Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Machine Learning-based Prognostic Subgrouping of Glioblastoma: A Multi-center Study.
Hamed Akbari, Spyridon Bakas, Chiharu Sako, Anahita Fathi Kazerooni, Javier Villanueva-Meyer
Neuro-Oncology. 2024-12-12
Local control and patient survival after stereotactic radiosurgery for esophageal cancer brain metastases: an international multicenter analysis.
Othman Bin-Alamer, Hussam Abou-Al-Shaar, Raj Singh, Greg Bowden, David Mathieu
Journal of Neurosurgery. 2024-12-06
Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases.
Vaseem M Khatri, Mariella A Mestres-Villanueva, Sreenija Yarlagadda, Ajay Doniparthi, David B Smith
NPJ Breast Cancer. 2024-11-21

Journal Articles

Primecuts- This week in the journals: Facts on the tip of my tongue
Palmer J, Clinical Correlations: The NYU Langone Online Journal of Medicine, 11/14/2011

Books/Book Chapters

New Frontiers- Re-Irradiation
Chapter: Brain tumours
Joshua D. Palmer, Colin Champ, Susan Short, Shannon E. FoghSpringer2016

Press Mentions

Louisiana Coronavirus Updates: Nearly 2,000 Dead, 29,340 Confirmed CasesMay 3rd, 2020
Primecuts – This Week in the JournalsNovember 14th, 2011
Radon Investigated as Cause of Over 100 Brain Tumors at New Jersey SchoolMay 13th, 2022
Join now to see all

Grant Support

Post-graduate Research AwardAlpha Omega Alpha Honor Society2014–Present
Oligometastatic stereotactic body radiation for pediatric patientsVarian Medical Systems2019–2023
Cognitive failure following salvage radiosurgery for brain metastasisOSU Departmental Seed Grant2019–2021

Committees

Member, American College of Radiation Oncology Education Sub-Committee 2014 - Present
Resident Member, Thomas Jefferson University Hospital Cancer Committee 2014 - Present
Voting Member, Jefferson Clinical Cancer Research Review Committee 2014 - Present
Executive Director of Academics, Academic Societies Executive Committee 2010 - 2011
Member, Department of Community Service (DOCS) Executive Committee 2010 - 2011